Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 5 | 2016 | 5319 | 0.170 |
Why?
|
| Allelic Imbalance | 1 | 2016 | 41 | 0.140 |
Why?
|
| Lung Neoplasms | 5 | 2016 | 11538 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2013 | 22 | 0.120 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 354 | 0.100 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 206 | 0.100 |
Why?
|
| Bronchi | 1 | 2012 | 326 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 419 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 488 | 0.090 |
Why?
|
| Genome, Human | 1 | 2016 | 1869 | 0.080 |
Why?
|
| Smoking | 2 | 2014 | 2440 | 0.070 |
Why?
|
| Transcriptome | 1 | 2014 | 1859 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 5159 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 1021 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2014 | 2819 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 8873 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 5437 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 7789 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 10035 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2016 | 13658 | 0.030 |
Why?
|
| Receptors, Vasoactive Intestinal Polypeptide, Type I | 1 | 2014 | 8 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 392 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 142 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 229 | 0.030 |
Why?
|
| Lung Injury | 1 | 2012 | 131 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 1053 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1165 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 460 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1077 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2012 | 474 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 1960 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 5395 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 1742 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 2450 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2291 | 0.020 |
Why?
|
| Prognosis | 2 | 2016 | 21713 | 0.020 |
Why?
|
| Pneumonia | 1 | 2012 | 751 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 6100 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 2508 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1678 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 2466 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 2738 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3981 | 0.020 |
Why?
|
| Lung | 1 | 2016 | 3151 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 4758 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 3443 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 4804 | 0.020 |
Why?
|
| Middle Aged | 3 | 2014 | 86204 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 7548 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 14889 | 0.010 |
Why?
|
| Humans | 5 | 2016 | 261506 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 7226 | 0.010 |
Why?
|
| Male | 3 | 2014 | 123000 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 12926 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 14551 | 0.010 |
Why?
|
| Female | 3 | 2014 | 141928 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 70117 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 10331 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 11965 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 77950 | 0.000 |
Why?
|